[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$3412m](/topic/$3412m)

### Top Social Posts

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$ONC BeOne Medicines Q325 Strong BRUKINSA Growth Raises FY25 Revenue Outlook Revenue: $1.41B (+41% YoY) 🟢 BRUKINSA Sales: $1.0B (+51% YoY; U.S. $739M Europe $163M) GAAP EPS: $XXXX Non-GAAP EPS: $XXXX 🟢 Gross Margin: XXXX% (vs. 82.8%) Adj. Op. Income: $341.2M (+420% YoY) Free Cash Flow: $354.5M (+548% YoY) FY25 Guidance Raised: Revenue $5.1$5.3B (prev. $5.0$5.3B) OpEx $4.1$4.3B Gross Margin mid-to-high XX% range 💬 BRUKINSA solidifies global BTKi leadership; strong pipeline progress in hematology and oncology"  
[X Link](https://x.com/allday_stocks/status/1986389404491866580) [@allday_stocks](/creator/x/allday_stocks) 2025-11-06T11:05Z 2095 followers, XXX engagements


"Heres how much Revenue Palantir $PLTR has brought in every quarter since going public Q3 2020: $289.4M Q4: $322.1M Q1 2021: $341.2M Q2: $375.6M Q3: $392.2M Q4: $432.9M Q1 2022: $446.4M Q2: $473M Q3: $477.9M Q4: $508.6M Q1 2023: $525.2M Q2: $533.3M Q3: $558.2M Q4: $608.4M Q1 2024: $634.3M Q2: $678M Q3: $726M Q4: $827.5M Q1 2025: $883.9M Q2 2025: $1B Q3 2025: $1.18B"  
[X Link](https://x.com/StockMKTNewz/status/1985461877145502146) [@StockMKTNewz](/creator/x/StockMKTNewz) 2025-11-03T21:39Z 660.9K followers, 111.5K engagements